Evidence map›Paper›PMID 35763323›Full record

ArticleDiabetes technology & therapeutics2022

Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations.

Gregory P Forlenza, Anders L Carlson, Rodolfo J Galindo, Davida F Kruger, Carol J Levy, Janet B McGill, Guillermo Umpierrez, Grazia Aleppo

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes technology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People With Type 1 Diabetes.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Review
  13. The Future of Automated Insulin Delivery Systems.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Review
  14. Article
  15. Registration and Real-Life Studies on Automated Insulin Delivery Systems.Journal of diabetes science and technology · 2025
    Review
  16. Early Stages of Automated Insulin Delivery.Diabetes technology & therapeutics · 2025
    Review
  17. Early Stages of Automated Insulin Delivery.Journal of diabetes science and technology · 2025
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Gregory P ForlenzaBarbara Davis Center, Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Denver, Denver, Colorado, USA.ORCID 0000-0003-3607-9788
Anders L CarlsonInternational Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.
Rodolfo J GalindoDivision of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-9295-3225
Davida F KrugerDivision of Endocrinology, Diabetes, Bone and Mineral, Henry Ford Health System, Detroit, Michigan, USA.
Carol J LevyDivision of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
Janet B McGillDivision of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0002-6228-6521
Guillermo UmpierrezDivision of Endocrinology, Metabolism Emory University School of Medicine, Atlanta, Georgia, USA.
Grazia AleppoDivision of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Emory University · USHealthPartners · USHenry Ford Health System · USIcahn School of Medicine at Mount Sinai · USNorthwestern University · USUniversity of Colorado Health · USWashington University in St. Louis · US

Funding

NYR-Diabetes Research Center (NYR-DRC)P30DK020541 · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2025 to 2025
$2.4M
Technologies Advancing Translation - Regional CoreP30DK111024 · EMORY UNIVERSITY · 2025 to 2025
$775k
Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease(ESRD) Patients with Type 2 DiabetesK23DK123384 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Rodolfo Galindo · 2022 to 2024
$369k
NCI NIH HHS R01 CA203584NIDDK NIH HHS K23 DK123384NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK111024NIDDK NIH HHS R01 DK125856
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2AgedBlood GlucoseBlood Glucose Self-MonitoringChildHumansHypoglycemic AgentsInsulinMedicaidMedicareRetrospective StudiesUnited StatesBlood GlucoseHypoglycemic AgentsInsulinDisparitiesHybrid closed loopSpecial populationsType 1 diabetesType 2 diabetes

Identifiers

PMID35763323
PMCPMC9618372
OpenAlexW4283695956

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.